Imagion Bio at The Edison Open House: Global Healthcare 2022

Imagion Bio at The Edison Open House: Global Healthcare 2022

Our CEO, Bob Proulx, connected with the Edison Group during their Global Healthcare Open House to discuss in detail, the nanotechnology behind our bio-imaging MagSense technology and where we hope to make a big difference in early cancer detection.

Watch the full interview here:

Visit our technology pages to learn more about our PrecisionMRX Nanoparticles or our MagSense Technology.

CONTACT US with any questions.

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.